Slate, Alveus Raise Hefty Series A Hauls for Migraine, Obesity Drugs

Slate Medicines will move forward with a migraine drug from a Chinese biotech, while Alveus Therapeutics will advance a dual GLP-1/GIPR fusion protein for weight loss.